Digoxin indications and usage: Difference between revisions
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Indications And Usage== | |||
====Heart Failure in Adults==== | |||
LANOXIN is indicated for the treatment of mild to moderate heart failure in adults. LANOXIN increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, LANOXIN should be used in combination with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor. | |||
====Heart Failure in Pediatric Patients==== | |||
Digoxin increases myocardial contractility in pediatric patients with heart failure. | |||
====Atrial Fibrillation in Adults==== | |||
LANOXIN is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LANOXIN (DIGOXIN) TABLET [COVIS PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7d0dba4-eb56-4631-90eb-1869cfaab436 | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LANOXIN (DIGOXIN) TABLET [COVIS PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7d0dba4-eb56-4631-90eb-1869cfaab436 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 14:32, 30 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications And Usage
Heart Failure in Adults
LANOXIN is indicated for the treatment of mild to moderate heart failure in adults. LANOXIN increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, LANOXIN should be used in combination with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor.
Heart Failure in Pediatric Patients
Digoxin increases myocardial contractility in pediatric patients with heart failure.
Atrial Fibrillation in Adults
LANOXIN is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. [1]
References
Adapted from the FDA Package Insert.